rx 336m has been researched along with pyrimidinones in 1 studies
| Studies (rx 336m) | Trials (rx 336m) | Recent Studies (post-2010) (rx 336m) | Studies (pyrimidinones) | Trials (pyrimidinones) | Recent Studies (post-2010) (pyrimidinones) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 6,059 | 604 | 2,692 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cowan, A | 1 |
1 other study(ies) available for rx 336m and pyrimidinones
| Article | Year |
|---|---|
RX 336-M, a new chemical tool in the analysis of the quasi-morphine withdrawal syndrome.
Topics: Animals; Codeine; Drug Tolerance; Humans; Hydroxamic Acids; Male; Morphine Dependence; Pyrimidinones; Rats; Shivering; Structure-Activity Relationship; Substance Withdrawal Syndrome; Thyrotropin-Releasing Hormone; Valproic Acid | 1981 |